Company profile
VentriPoint Diagnostics Ltd.
OTC: VPTDF · Healthcare · Medical - Devices
Canadian filerHQ Toronto, ONReports USD
#1026 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
31DFH 18DQ —GM 67SS 41
v0.1 · 45/100 weight · provisional
↑ revenue growth (YoY), 3-yr revenue growth · ↓ return on assets, Altman-Z
Methodology →Revenue TTM
$128.5k
Rev growth YoY (TTM)
+84.4%
Net income (FY)
-$2.3M
Employees
3
as of 2026-08-22
Market cap
$13.8M
as of 2026-08-22
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$128.6k179.8k CAD2025
Net income-$2.3M-3.2M CAD2025
Operating income-$2.4M-3.4M CAD2025
Total assets$344.2k471.7k CAD2025
Liabilities$3.3M4.6M CAD2025
Equity-$3.0M-4.1M CAD2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is VentriPoint Diagnostics Ltd.’s revenue?
VentriPoint Diagnostics Ltd. booked $128.6k in FY2025 revenue, growing 85% year over year — faster than most Healthcare companies we track, at a -1778.6% net margin.
Peers · Healthcare
Sigyn Therapeutics, Inc.——Endonovo Therapeutics, Inc.——Serina Therapeutics, Inc.41DPanamera Holdings Corporation31DCandel Therapeutics, Inc.33DAinos, Inc.41DKey facts
CEOHugh MacNaught
SectorHealthcare
IndustryMedical - Devices
HeadquartersToronto, ON
ExchangeOTC: VPTDF
Employees3
IPO date2010-09-22
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.